Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Hubei Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosed Novel coronavirus pneumonia patients or clinically diagnosed NCP patients in Hubei Province; 2. Aged 18 to 65 years; 3. The time interval between symptom onset and randomization was within 7 days (the onset of symptom was mainly determined by the time of fever); 4. Sign the written informed consent before the study.
Exclusion criteria
Exclusion criteria: 1. There is clear evidence of bacterial infection in respiratory tract infection caused by basic diseases such as primary immunodeficiency disease, congenital respiratory tract malformation, congenital heart disease, gastroesophageal reflux disease and pulmonary dysplasia; 2. Subjects with the following conditions: asthma requiring daily treatment, any other chronic respiratory disease, respiratory system bacterial infection such as suppurative tonsillitis, acute bronchitis, sinusitis, otitis media or other respiratory diseases affecting the evaluation of clinical trials. Or with Chest CT confirmed the presence of serious interstitial lung disease, bronchiectasis and other basic lung diseases; 3. critically ill patients based on the New Protocol for Diagnosis and Treatment of NCP; 4. Severe liver disease (such as child Pugh score >=C, AST > 5 ULN); 5. Patients with severe renal insufficiency (estimated glomerular filtration rate <=30ml/min/1.73m2) or continuous renal replacement therapy, hemodialysis or peritoneal dialysis; 6. Pregnant or breast-feeding women; 7. Patients may be transferred to non-designated hospitals within 72 hours; 8. Patients who have participated in other clinical trials in the past 7 days; 9. Allergic constitution, such as those who are allergic to two or over twodrugs ,with history of food allergies, or known to be allergic to the ingredients of this drug; 10. In the opinion of the investigator, subjects who are not suitable for enrollment or with any factors that affect the outcome of the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pneumonia psi score;Recovery time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clearance rate of single symptom;Clearance rate and time of main symptoms (fever, fatigue, cough\Gastrointestinal discomfort, chest tightness);Chest imaging score;Exacerbation (transfer to RICU) time;Time and rate of coronavirus become negative; | — |
Countries
China
Contacts
Public ContactYang Yi
Hubei Hospital of Traditional Chinese Medicine
Outcome results
None listed